A REVIEW OF HEMGENIX

Number of eligible patients: CDEC talked about the uncertainty in the volume of sufferers with reasonably significant to severe hemophilia B in Canada qualified for etranacogene dezaparvovec. Scientific authorities consulted by CADTH indicated that some patients who're labeled as getting gentle or reasonable sickness could possibly have a severe bl